Athena Countouriotis, President & CEO at Turning Point Therapeutics, Inc. (TPTX), bought 12,000 shares at $18.00 ($216K) on 2019-04-22, disclosed to the SEC on 2019-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TPTX | BUY | 2020-05-26 | $250K | — | Filing → |
| PASG | BUY | 2020-03-25 | $150K | — | Filing → |
| PASG | BUY | 2020-03-03 | $160K | — | Filing → |